ICP Parking Lot/Vaccines: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
No edit summary
 
(8 intermediate revisions by the same user not shown)
Line 1: Line 1:
* Authors: Carolina Rossini
{{TOCright}}
 
=Talks=
= [[Vaccines/Glossary|Research Vocabulary]] =
* [[Vaccines/Sara Crager on Vaccines]]
 
=Vaccines/Bibliography|Bibliography=
=Structured Rational for the Paper=
* 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf
# [[Vaccines/The_Argument_Framework|The Argument Framework]]
* Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at:  www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
 
*  Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/.
=Study of the field=
* LUDWIG,STEVEN R. (2009) Data Exclusivity – A Necessary Form of Intellectual Property. Available at: www.iptoday.com/pdf/2007/8/Ludwig-Aug2007.pdf
 
* Will HPV Vaccines Prevent Cervical Cancers Among Poor Women of Color?: Global Health Policy at the Intersection of Human Rights and Intellectual Property Law, Kevin Outterson. 2009, 35 Am. J. L. and Med.
Analysis of the field with basis on [https://cyber.law.harvard.edu/commonsbasedresearch/Field_Research_Methodology Field Research Methodology]
* University Contributions to the HPV Vaccine and Implications for Access to Vaccines in Developing Countries: Addressing Materials and Know-How in University Technology Transfer Policy, Sara E. Crager, Ethan Guillen, & Matt Price. 2009, 35 Am. J. L. and Med.
 
* The Global Health Licensing Program: A New Model for Humanitarian Licensing at the University Level, Beirne Roose-Snyder & Megan K. Doyle. 2009, 35 Am. J. L. and Med.
# [[Overview of Economics of Intellectual Property in Vaccines]]
* New Vaccines for Developing Countries: Will it be Feast or Famine?, Jon Kim Andrus, MD, + Ciro de Quadros, MD, MPH, Cuauhtemoc Ruiz Matus, MD, MPH, Silvana Luciani MHSc, & Peter Hotez, MD, PhD. 2009, 35 Am. J. L. and Med.
# [[Give an overall picture of the Vaccines' sector]]
* Compulsory Licenses: A Tool to Improve Global Access to the HPV Vaccine?, Peter Maybardule & Sarah Rimmingto. 2009, 35 Am. J. L. and Med.
# Outputs and Products of the field: [[data, narratives and tools produced by the Vaccines' sector]]
* Clinical Preventive Services for Adolescents: Position Paper of the Society for Adolescent Medicine, Abigail English, Carol A. Ford, & John S. Santelli. 2009, 35 Am. J. L. and Med.
# Legal tools available for and in use by the actors of Vaccines' sector: [[IP in Vaccines]]
* Human Rights In Health Equity: Cervical Cancer and HPV Vaccines, Joanna N. Erdman. 2009, 35 Am. J. L. and Med.
# [[competitive advantages in Vaccines]]
* Potential Barriers to HPV Immunization: From Public Health to Personal Choice, Gregory D. Zimet. 2009, 35 Am. J. L. and Med.
# [[IP Profile of Biggest for-profit companies in Vaccines]]
* Overcoming Barriers and Ensuring Access to HPV Vaccines in Low-Income Countries, Vivien Davis Tsu. 2009, 35 Am. J. L. and Med.
# [[IP Profile of non-profit companies in Vaccines]]
* Addressing Supply Side Barriers to Introduction of New Vaccines to the Developing World, Sean McElligott
# [[IP Profile of Universities working in Vaccines]]
# [[IP Profile of Associations in Vaccines]]
# [[Commons based cases in Vaccines]]
# [[Peer-Production Business models in Vaccines]]
# [[Open Business models in Vaccines]]
 
=[[Vaccines/Bibliography|Bibliography]]=
 
CAROL HAVE DONE LITERATURE REVIEW AND NEEDS TO INSERT IN THE WIKI
 
'''American Society of Law, Medicine & Ethics, Inc., and Boston University American Journal of Law & Medicine, 2009, 35 Am. J. L. and Med.:'''
 
p. 247, Will HPV Vaccines Prevent Cervical Cancers Among Poor Women of Color?: Global Health Policy at the Intersection of Human Rights and Intellectual Property Law, Kevin Outterson  
 
p. 253, University Contributions to the HPV Vaccine and Implications for Access to Vaccines in Developing Countries: Addressing Materials and Know-How in University Technology Transfer Policy, Sara E. Crager, Ethan Guillen, & Matt Price
 
p. 281, The Global Health Licensing Program: A New Model for Humanitarian Licensing at the University Level, Beirne Roose-Snyder & Megan K. Doyle  
 
p. 311, New Vaccines for Developing Countries: Will it be Feast or Famine?, Jon Kim Andrus, MD, + Ciro de Quadros, MD, MPH, Cuauhtemoc Ruiz Matus, MD, MPH, Silvana Luciani MHSc, & Peter Hotez, MD, PhD  
 
p. 323, Compulsory Licenses: A Tool to Improve Global Access to the HPV Vaccine?, Peter Maybardule & Sarah Rimmingto
 
p. 351, Clinical Preventive Services for Adolescents: Position Paper of the Society for Adolescent Medicine, Abigail English, Carol A. Ford, & John S. Santelli
 
p. 365, Human Rights In Health Equity: Cervical Cancer and HPV Vaccines, Joanna N. Erdman
 
p. 389, Potential Barriers to HPV Immunization: From Public Health to Personal Choice, Gregory D. Zimet  
 
p. 401, 7040 words, ARTICLE: Overcoming Barriers and Ensuring Access to HPV Vaccines in Low-Income Countries, Vivien Davis Tsu
 
p. 415, Addressing Supply Side Barriers to Introduction of New Vaccines to the Developing World, Sean McElligott
 
'''Follow-On Biologics: Intellectual Property and Innovation Issues'''
introduces innovation policy issues pertaining to follow-on biologics. @http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf
 
'''Emerging Health Care Issues: Follow-on Biologic Drug Competition'''
@www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
 
=[[Vaccines/Interviews|Interviews]]=
''' Completed '''
 
'''Recommended'''
 
''' Upcoming? '''
 
=Blogs And News=
''' News'''
''' Blogs '''


=Navigation=
=Navigation=
Back to [[Main Page]]
Back to [[ICP Parking Lot]]<br>
Back to [[Biotechnology_-_Genomic_and_Proteomics]]
Back to [[Biotechnology_-_Genomic_and_Proteomics]]<br>
Back to [[Main Page]]<br>

Latest revision as of 20:12, 5 May 2010

Talks

Vaccines/Bibliography|Bibliography

  • 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf
  • Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at: www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
  • Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/.
  • LUDWIG,STEVEN R. (2009) Data Exclusivity – A Necessary Form of Intellectual Property. Available at: www.iptoday.com/pdf/2007/8/Ludwig-Aug2007.pdf
  • Will HPV Vaccines Prevent Cervical Cancers Among Poor Women of Color?: Global Health Policy at the Intersection of Human Rights and Intellectual Property Law, Kevin Outterson. 2009, 35 Am. J. L. and Med.
  • University Contributions to the HPV Vaccine and Implications for Access to Vaccines in Developing Countries: Addressing Materials and Know-How in University Technology Transfer Policy, Sara E. Crager, Ethan Guillen, & Matt Price. 2009, 35 Am. J. L. and Med.
  • The Global Health Licensing Program: A New Model for Humanitarian Licensing at the University Level, Beirne Roose-Snyder & Megan K. Doyle. 2009, 35 Am. J. L. and Med.
  • New Vaccines for Developing Countries: Will it be Feast or Famine?, Jon Kim Andrus, MD, + Ciro de Quadros, MD, MPH, Cuauhtemoc Ruiz Matus, MD, MPH, Silvana Luciani MHSc, & Peter Hotez, MD, PhD. 2009, 35 Am. J. L. and Med.
  • Compulsory Licenses: A Tool to Improve Global Access to the HPV Vaccine?, Peter Maybardule & Sarah Rimmingto. 2009, 35 Am. J. L. and Med.
  • Clinical Preventive Services for Adolescents: Position Paper of the Society for Adolescent Medicine, Abigail English, Carol A. Ford, & John S. Santelli. 2009, 35 Am. J. L. and Med.
  • Human Rights In Health Equity: Cervical Cancer and HPV Vaccines, Joanna N. Erdman. 2009, 35 Am. J. L. and Med.
  • Potential Barriers to HPV Immunization: From Public Health to Personal Choice, Gregory D. Zimet. 2009, 35 Am. J. L. and Med.
  • Overcoming Barriers and Ensuring Access to HPV Vaccines in Low-Income Countries, Vivien Davis Tsu. 2009, 35 Am. J. L. and Med.
  • Addressing Supply Side Barriers to Introduction of New Vaccines to the Developing World, Sean McElligott

Navigation

Back to ICP Parking Lot
Back to Biotechnology_-_Genomic_and_Proteomics
Back to Main Page

Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=ICP_Parking_Lot/Vaccines&oldid=7210"